Shawn Lynch

Shawn Lynch has resigned from his position as CFO of T2 Biosystems, effective immediately. According to a Form 8K the company filed this week with the US Securities and Exchange Commission, Lynch left for personal reasons and not as the result of a disagreement with management or the board.


Jay Shendure, Shankar Balasubramanian, Wolf Reik, Anjana Rao

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.